Rank | Gene Set | Z-score |
---|---|---|
1 | proteasome assembly (GO:0043248) | 5.56747433 |
2 | ribosome assembly (GO:0042255) | 4.93725150 |
3 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.39552590 |
4 | desmosome organization (GO:0002934) | 4.23309001 |
5 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.21584133 |
6 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.14834632 |
7 | negative regulation of ligase activity (GO:0051352) | 4.14834632 |
8 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.12783437 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.11645172 |
10 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.03465998 |
11 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.96478458 |
12 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.95303466 |
13 | CENP-A containing nucleosome assembly (GO:0034080) | 3.90966805 |
14 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.82714389 |
15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.82379216 |
16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.77131959 |
17 | response to interferon-alpha (GO:0035455) | 3.74076693 |
18 | chromatin remodeling at centromere (GO:0031055) | 3.64822529 |
19 | phospholipid scrambling (GO:0017121) | 3.60061988 |
20 | endosome to melanosome transport (GO:0035646) | 3.55851343 |
21 | endosome to pigment granule transport (GO:0043485) | 3.55851343 |
22 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.54410074 |
23 | positive regulation of ligase activity (GO:0051351) | 3.50255445 |
24 | establishment of integrated proviral latency (GO:0075713) | 3.45989723 |
25 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.44615114 |
26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42644139 |
27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42644139 |
28 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.38925356 |
29 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.38925356 |
30 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.38553619 |
31 | ribosomal large subunit biogenesis (GO:0042273) | 3.36951895 |
32 | establishment of viral latency (GO:0019043) | 3.36684493 |
33 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.36417755 |
34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.36417755 |
35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.36417755 |
36 | regulation of ligase activity (GO:0051340) | 3.35761199 |
37 | protein neddylation (GO:0045116) | 3.33772544 |
38 | platelet dense granule organization (GO:0060155) | 3.33463160 |
39 | hemidesmosome assembly (GO:0031581) | 3.30020329 |
40 | regulation of metalloenzyme activity (GO:0048552) | 3.29744057 |
41 | membrane budding (GO:0006900) | 3.26783213 |
42 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.24600694 |
43 | formation of translation preinitiation complex (GO:0001731) | 3.23027547 |
44 | intestinal epithelial cell development (GO:0060576) | 3.21669258 |
45 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.21444492 |
46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.21444492 |
47 | response to interferon-beta (GO:0035456) | 3.18160054 |
48 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.16713900 |
49 | barbed-end actin filament capping (GO:0051016) | 3.15543825 |
50 | cullin deneddylation (GO:0010388) | 3.14044962 |
51 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.13909481 |
52 | DNA double-strand break processing (GO:0000729) | 3.13331748 |
53 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.12347434 |
54 | histone exchange (GO:0043486) | 3.08189240 |
55 | respiratory chain complex IV assembly (GO:0008535) | 3.07785586 |
56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.07460868 |
57 | negative regulation of protein ubiquitination (GO:0031397) | 3.05476009 |
58 | mitotic metaphase plate congression (GO:0007080) | 3.02399180 |
59 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.96403697 |
60 | adhesion of symbiont to host cell (GO:0044650) | 2.95909410 |
61 | virion attachment to host cell (GO:0019062) | 2.95909410 |
62 | regulation of helicase activity (GO:0051095) | 2.90893288 |
63 | protein deneddylation (GO:0000338) | 2.89086968 |
64 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.86213217 |
65 | chaperone-mediated protein transport (GO:0072321) | 2.85546832 |
66 | regulation of cellular amine metabolic process (GO:0033238) | 2.83945715 |
67 | transcytosis (GO:0045056) | 2.83279625 |
68 | spindle checkpoint (GO:0031577) | 2.82123331 |
69 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.80493685 |
70 | ventricular cardiac muscle cell development (GO:0055015) | 2.80108100 |
71 | neutrophil activation involved in immune response (GO:0002283) | 2.78070639 |
72 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.78043617 |
73 | ATP synthesis coupled proton transport (GO:0015986) | 2.78043617 |
74 | regulation of histone phosphorylation (GO:0033127) | 2.76573131 |
75 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.75247545 |
76 | negative regulation of sister chromatid segregation (GO:0033046) | 2.75247545 |
77 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.75247545 |
78 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.75247545 |
79 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.75247545 |
80 | mitotic spindle checkpoint (GO:0071174) | 2.74404659 |
81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74335421 |
82 | cellular protein complex localization (GO:0034629) | 2.74188987 |
83 | metaphase plate congression (GO:0051310) | 2.73684144 |
84 | regulation of mitochondrial translation (GO:0070129) | 2.72914917 |
85 | cell cycle G1/S phase transition (GO:0044843) | 2.72220866 |
86 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.72220866 |
87 | fucose catabolic process (GO:0019317) | 2.72193087 |
88 | L-fucose metabolic process (GO:0042354) | 2.72193087 |
89 | L-fucose catabolic process (GO:0042355) | 2.72193087 |
90 | rRNA modification (GO:0000154) | 2.70448103 |
91 | DNA replication-independent nucleosome organization (GO:0034724) | 2.70428012 |
92 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.70428012 |
93 | DNA damage response, detection of DNA damage (GO:0042769) | 2.70370920 |
94 | daunorubicin metabolic process (GO:0044597) | 2.69784226 |
95 | polyketide metabolic process (GO:0030638) | 2.69784226 |
96 | doxorubicin metabolic process (GO:0044598) | 2.69784226 |
97 | purine nucleobase biosynthetic process (GO:0009113) | 2.69065947 |
98 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.67706026 |
99 | histone mRNA metabolic process (GO:0008334) | 2.66070395 |
100 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.64021481 |
101 | spindle assembly checkpoint (GO:0071173) | 2.62881716 |
102 | signal peptide processing (GO:0006465) | 2.62711445 |
103 | regulation of meiosis I (GO:0060631) | 2.62410853 |
104 | xenobiotic catabolic process (GO:0042178) | 2.61273374 |
105 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.60973404 |
106 | protein localization to kinetochore (GO:0034501) | 2.60056442 |
107 | protein targeting to mitochondrion (GO:0006626) | 2.59204035 |
108 | regulation of natural killer cell differentiation (GO:0032823) | 2.58582186 |
109 | negative regulation of chromosome segregation (GO:0051985) | 2.58276474 |
110 | mitotic spindle assembly checkpoint (GO:0007094) | 2.58019816 |
111 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.57568326 |
112 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.57495190 |
113 | AMP metabolic process (GO:0046033) | 2.55713899 |
114 | tricarboxylic acid cycle (GO:0006099) | 2.54595106 |
115 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.54224894 |
116 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.53565858 |
117 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.53565858 |
118 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.53254162 |
119 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.53254162 |
120 | respiratory electron transport chain (GO:0022904) | 2.53137428 |
121 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.52829914 |
122 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.50501752 |
123 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.49678026 |
124 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.47996954 |
125 | positive regulation of cell cycle arrest (GO:0071158) | 2.47913691 |
126 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.47409303 |
127 | mitotic G2/M transition checkpoint (GO:0044818) | 2.47379299 |
128 | protein K11-linked ubiquitination (GO:0070979) | 2.46840481 |
129 | protein localization to mitochondrion (GO:0070585) | 2.46815694 |
130 | electron transport chain (GO:0022900) | 2.46601220 |
131 | adhesion of symbiont to host (GO:0044406) | 2.45645441 |
132 | pentose-phosphate shunt (GO:0006098) | 2.44088687 |
133 | negative regulation of viral entry into host cell (GO:0046597) | 2.43606646 |
134 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.43373066 |
135 | negative regulation of biomineral tissue development (GO:0070168) | 2.39895387 |
136 | cell adhesion mediated by integrin (GO:0033627) | 2.39079389 |
137 | sexual reproduction (GO:0019953) | 2.38411292 |
138 | interferon-gamma secretion (GO:0072643) | 2.31980322 |
139 | protein targeting to plasma membrane (GO:0072661) | 2.26479996 |
140 | NADPH regeneration (GO:0006740) | 2.26218949 |
141 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.25779983 |
142 | cellular response to interferon-alpha (GO:0035457) | 2.25278362 |
143 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.25088289 |
144 | wound healing, spreading of epidermal cells (GO:0035313) | 2.24358178 |
145 | galactose catabolic process (GO:0019388) | 2.21688660 |
146 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.19875530 |
147 | response to host immune response (GO:0052572) | 2.19875530 |
148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.19431501 |
149 | definitive hemopoiesis (GO:0060216) | 2.19097188 |
150 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.18867252 |
151 | positive regulation of lamellipodium assembly (GO:0010592) | 2.18803707 |
152 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.18377406 |
153 | production of molecular mediator of immune response (GO:0002440) | 2.16831921 |
154 | regulation of viral entry into host cell (GO:0046596) | 2.14597921 |
155 | negative regulation of bone mineralization (GO:0030502) | 2.14458966 |
156 | platelet aggregation (GO:0070527) | 2.14184205 |
157 | positive regulation of pseudopodium assembly (GO:0031274) | 2.12554145 |
158 | cell wall macromolecule catabolic process (GO:0016998) | 2.12290873 |
159 | cell wall macromolecule metabolic process (GO:0044036) | 2.12290873 |
160 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.11779608 |
161 | peptide catabolic process (GO:0043171) | 2.11689960 |
162 | sperm capacitation (GO:0048240) | 2.10840652 |
163 | respiratory tube development (GO:0030323) | 2.10156404 |
164 | membrane raft organization (GO:0031579) | 2.08968642 |
165 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.08207379 |
166 | type B pancreatic cell proliferation (GO:0044342) | 2.07554653 |
167 | regulation of ruffle assembly (GO:1900027) | 2.07458988 |
168 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.06895012 |
169 | establishment of skin barrier (GO:0061436) | 2.06819021 |
170 | low-density lipoprotein particle clearance (GO:0034383) | 2.04832802 |
171 | mitochondrial calcium ion transport (GO:0006851) | 2.04712837 |
172 | membrane invagination (GO:0010324) | 2.04679397 |
173 | apoptotic cell clearance (GO:0043277) | 2.04405080 |
174 | Golgi transport vesicle coating (GO:0048200) | 2.03901126 |
175 | COPI coating of Golgi vesicle (GO:0048205) | 2.03901126 |
176 | heparin biosynthetic process (GO:0030210) | 2.02873133 |
177 | heparin metabolic process (GO:0030202) | 2.02873133 |
178 | O-glycan processing (GO:0016266) | 2.02632865 |
179 | fibroblast migration (GO:0010761) | 2.02539735 |
180 | pattern specification involved in kidney development (GO:0061004) | 2.01756758 |
181 | protein retention in ER lumen (GO:0006621) | 2.01634205 |
182 | cellular response to vitamin (GO:0071295) | 2.01448484 |
183 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.01212372 |
184 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.00422156 |
185 | phagocytosis, recognition (GO:0006910) | 2.00406007 |
186 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.00008914 |
187 | phagocytosis, engulfment (GO:0006911) | 1.99147542 |
188 | plasma membrane fusion (GO:0045026) | 1.98399832 |
189 | cellular response to type I interferon (GO:0071357) | 1.97237164 |
190 | type I interferon signaling pathway (GO:0060337) | 1.97237164 |
191 | maintenance of gastrointestinal epithelium (GO:0030277) | 1.96673299 |
192 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 1.96135394 |
193 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 1.96119355 |
194 | melanosome organization (GO:0032438) | 1.95687788 |
195 | response to host (GO:0075136) | 1.95625957 |
196 | response to host defenses (GO:0052200) | 1.95625957 |
197 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 1.95625957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.41357196 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.30946071 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.86020932 |
4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.62772117 |
5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.48044860 |
6 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.19766252 |
7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.07884509 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98952467 |
9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.92635248 |
10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.82657912 |
11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.80725143 |
12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.75992712 |
13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.65265849 |
14 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.47614869 |
15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.44524032 |
16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.44117252 |
17 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.38070231 |
18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.32186909 |
19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.29912371 |
20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.23487943 |
21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.21735874 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16610163 |
23 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.14618382 |
24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.13589355 |
25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12715975 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10057611 |
27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.09987123 |
28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07115221 |
29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.06554734 |
30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04863046 |
31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01548124 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99982897 |
33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.99833375 |
34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97620495 |
35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.97556662 |
36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.95802931 |
37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90613590 |
38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.88155917 |
39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87378294 |
40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85936646 |
41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85205527 |
42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84729146 |
43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82758409 |
44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82243125 |
45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.81517192 |
46 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.78754187 |
47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76779938 |
48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.76360321 |
49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76013802 |
50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75295619 |
51 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.72632579 |
52 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.71782433 |
53 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.71643580 |
54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.68016050 |
55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.67602433 |
56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.67602433 |
57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66280357 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.66040042 |
59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.66040042 |
60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.65289931 |
61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64218682 |
62 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.63487874 |
63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61133386 |
64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59777863 |
65 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.58864149 |
66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.58814887 |
67 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.57556166 |
68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.57501543 |
69 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.54496391 |
70 | CJUN_26792858_Chip-Seq_BT549_Human | 1.54400687 |
71 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.53911991 |
72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.50168734 |
73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50032870 |
74 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.49506975 |
75 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.49506975 |
76 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.49506975 |
77 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49438443 |
78 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48601687 |
79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47178590 |
80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45527794 |
81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45341218 |
82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43767833 |
83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.42528937 |
84 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.41495548 |
85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40425630 |
86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39674481 |
87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.36463227 |
88 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35529440 |
89 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.35012509 |
90 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34582156 |
91 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.34465471 |
92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33277998 |
93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.32148638 |
94 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30929518 |
95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30730073 |
96 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.29632317 |
97 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28939364 |
98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27531124 |
99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27227340 |
100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26379663 |
101 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24948021 |
102 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.24773595 |
103 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.23747990 |
104 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23467078 |
105 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.22577221 |
106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21911163 |
107 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18562238 |
108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18490690 |
109 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14845034 |
110 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13391472 |
111 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13315694 |
112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11133446 |
113 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10921752 |
114 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10631847 |
115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08538422 |
116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08172245 |
117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07626657 |
118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07091150 |
119 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06452562 |
120 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05702536 |
121 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.05532983 |
122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04403263 |
123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04101516 |
124 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.04033933 |
125 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03856038 |
126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03842859 |
127 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03024374 |
128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02654480 |
129 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02549403 |
130 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.02491230 |
131 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02360288 |
132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01223985 |
133 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00769502 |
134 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00745879 |
135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00467753 |
136 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99594445 |
137 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99375523 |
138 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98680308 |
139 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97539874 |
140 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.96461819 |
141 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.96089059 |
142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95441837 |
143 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94828509 |
144 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93752887 |
145 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93716108 |
146 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93677048 |
147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92884230 |
148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92773660 |
149 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92773365 |
150 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.92748954 |
151 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92507526 |
152 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92451295 |
153 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92201766 |
154 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90398716 |
155 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89988847 |
156 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89761354 |
157 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88542325 |
158 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88215987 |
159 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88103768 |
160 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.87773367 |
161 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87581682 |
162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87142892 |
163 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86988803 |
164 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86336340 |
165 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85583513 |
166 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84656225 |
167 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84507228 |
168 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83908332 |
169 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82447717 |
170 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82367626 |
171 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.81740822 |
172 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.81707873 |
173 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.81674362 |
174 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.81529835 |
175 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79686272 |
176 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77906144 |
177 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.77626063 |
178 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74600279 |
179 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74288640 |
180 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.74194262 |
181 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73851002 |
182 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.73144187 |
183 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.73058992 |
184 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.71442039 |
185 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71009932 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 5.33574711 |
2 | MP0005275_abnormal_skin_tensile | 3.62855199 |
3 | MP0006054_spinal_hemorrhage | 3.53066417 |
4 | MP0004957_abnormal_blastocyst_morpholog | 3.24870174 |
5 | MP0003693_abnormal_embryo_hatching | 3.04665804 |
6 | MP0002877_abnormal_melanocyte_morpholog | 2.69756828 |
7 | MP0003941_abnormal_skin_development | 2.64110777 |
8 | MP0002796_impaired_skin_barrier | 2.51112697 |
9 | MP0008438_abnormal_cutaneous_collagen | 2.50970224 |
10 | MP0008057_abnormal_DNA_replication | 2.29993216 |
11 | MP0008058_abnormal_DNA_repair | 2.26219969 |
12 | MP0009785_altered_susceptibility_to | 2.20564726 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.17258472 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.12635621 |
15 | MP0001958_emphysema | 2.09054015 |
16 | MP0000372_irregular_coat_pigmentation | 2.05616064 |
17 | MP0003436_decreased_susceptibility_to | 1.92517058 |
18 | MP0001849_ear_inflammation | 1.90724242 |
19 | MP0010094_abnormal_chromosome_stability | 1.89236490 |
20 | MP0005408_hypopigmentation | 1.87009996 |
21 | MP0003566_abnormal_cell_adhesion | 1.86949204 |
22 | MP0009697_abnormal_copulation | 1.83316786 |
23 | MP0003077_abnormal_cell_cycle | 1.81391782 |
24 | MP0004947_skin_inflammation | 1.80147625 |
25 | MP0001879_abnormal_lymphatic_vessel | 1.79845917 |
26 | MP0003300_gastrointestinal_ulcer | 1.71915199 |
27 | MP0003724_increased_susceptibility_to | 1.68411815 |
28 | MP0003718_maternal_effect | 1.65402977 |
29 | MP0003111_abnormal_nucleus_morphology | 1.64794879 |
30 | MP0008004_abnormal_stomach_pH | 1.62617621 |
31 | MP0008932_abnormal_embryonic_tissue | 1.61880024 |
32 | MP0005464_abnormal_platelet_physiology | 1.61333395 |
33 | MP0009379_abnormal_foot_pigmentation | 1.61207552 |
34 | MP0002060_abnormal_skin_morphology | 1.60684940 |
35 | MP0003453_abnormal_keratinocyte_physiol | 1.60542330 |
36 | MP0005501_abnormal_skin_physiology | 1.59791678 |
37 | MP0008007_abnormal_cellular_replicative | 1.59476785 |
38 | MP0005058_abnormal_lysosome_morphology | 1.57209535 |
39 | MP0010352_gastrointestinal_tract_polyps | 1.56964726 |
40 | MP0006036_abnormal_mitochondrial_physio | 1.56564740 |
41 | MP0003279_aneurysm | 1.55888858 |
42 | MP0002148_abnormal_hypersensitivity_rea | 1.55532971 |
43 | MP0005248_abnormal_Harderian_gland | 1.55495878 |
44 | MP0010368_abnormal_lymphatic_system | 1.54107751 |
45 | MP0005360_urolithiasis | 1.53626889 |
46 | MP0010678_abnormal_skin_adnexa | 1.50943177 |
47 | MP0004272_abnormal_basement_membrane | 1.50610702 |
48 | MP0000343_altered_response_to | 1.48194709 |
49 | MP0005023_abnormal_wound_healing | 1.45595384 |
50 | MP0001851_eye_inflammation | 1.45462323 |
51 | MP0001533_abnormal_skeleton_physiology | 1.44044759 |
52 | MP0000516_abnormal_urinary_system | 1.43271190 |
53 | MP0005367_renal/urinary_system_phenotyp | 1.43271190 |
54 | MP0005165_increased_susceptibility_to | 1.42790910 |
55 | MP0003786_premature_aging | 1.40710999 |
56 | MP0000465_gastrointestinal_hemorrhage | 1.40623386 |
57 | MP0010155_abnormal_intestine_physiology | 1.40387847 |
58 | MP0005085_abnormal_gallbladder_physiolo | 1.39908113 |
59 | MP0003890_abnormal_embryonic-extraembry | 1.39468875 |
60 | MP0000647_abnormal_sebaceous_gland | 1.38934341 |
61 | MP0002254_reproductive_system_inflammat | 1.36064301 |
62 | MP0003075_altered_response_to | 1.33667676 |
63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33651329 |
64 | MP0001764_abnormal_homeostasis | 1.33440730 |
65 | MP0001853_heart_inflammation | 1.29022808 |
66 | MP0004782_abnormal_surfactant_physiolog | 1.28666445 |
67 | MP0001216_abnormal_epidermal_layer | 1.28545705 |
68 | MP0001873_stomach_inflammation | 1.27785887 |
69 | MP0002009_preneoplasia | 1.26563342 |
70 | MP0005025_abnormal_response_to | 1.24750332 |
71 | MP0001881_abnormal_mammary_gland | 1.23984890 |
72 | MP0001835_abnormal_antigen_presentation | 1.21881084 |
73 | MP0003195_calcinosis | 1.21725079 |
74 | MP0003329_amyloid_beta_deposits | 1.20676310 |
75 | MP0010307_abnormal_tumor_latency | 1.20230936 |
76 | MP0002419_abnormal_innate_immunity | 1.19627753 |
77 | MP0002295_abnormal_pulmonary_circulatio | 1.19599700 |
78 | MP0005397_hematopoietic_system_phenotyp | 1.19106007 |
79 | MP0001545_abnormal_hematopoietic_system | 1.19106007 |
80 | MP0005187_abnormal_penis_morphology | 1.16643411 |
81 | MP0009840_abnormal_foam_cell | 1.15101895 |
82 | MP0001666_abnormal_nutrient_absorption | 1.14913534 |
83 | MP0003303_peritoneal_inflammation | 1.14411109 |
84 | MP0000350_abnormal_cell_proliferation | 1.13909633 |
85 | MP0005166_decreased_susceptibility_to | 1.13901028 |
86 | MP0003186_abnormal_redox_activity | 1.11662511 |
87 | MP0000627_abnormal_mammary_gland | 1.11604924 |
88 | MP0002098_abnormal_vibrissa_morphology | 1.11281558 |
89 | MP0004264_abnormal_extraembryonic_tissu | 1.11005159 |
90 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10784701 |
91 | MP0010386_abnormal_urinary_bladder | 1.10672655 |
92 | MP0009764_decreased_sensitivity_to | 1.09873462 |
93 | MP0000685_abnormal_immune_system | 1.09028886 |
94 | MP0010771_integument_phenotype | 1.08604639 |
95 | MP0005164_abnormal_response_to | 1.08260003 |
96 | MP0001243_abnormal_dermal_layer | 1.07971639 |
97 | MP0000604_amyloidosis | 1.07925890 |
98 | MP0002837_dystrophic_cardiac_calcinosis | 1.07763369 |
99 | MP0000377_abnormal_hair_follicle | 1.07511544 |
100 | MP0001730_embryonic_growth_arrest | 1.04650037 |
101 | MP0005410_abnormal_fertilization | 1.04495800 |
102 | MP0000538_abnormal_urinary_bladder | 1.03299307 |
103 | MP0004215_abnormal_myocardial_fiber | 1.01840833 |
104 | MP0004808_abnormal_hematopoietic_stem | 1.01829528 |
105 | MP0005084_abnormal_gallbladder_morpholo | 0.99820050 |
106 | MP0001542_abnormal_bone_strength | 0.98246199 |
107 | MP0002282_abnormal_trachea_morphology | 0.95819730 |
108 | MP0005000_abnormal_immune_tolerance | 0.95734890 |
109 | MP0001188_hyperpigmentation | 0.94970946 |
110 | MP0002166_altered_tumor_susceptibility | 0.94075266 |
111 | MP0004858_abnormal_nervous_system | 0.93529923 |
112 | MP0003806_abnormal_nucleotide_metabolis | 0.92602051 |
113 | MP0005390_skeleton_phenotype | 0.92564698 |
114 | MP0008873_increased_physiological_sensi | 0.91928735 |
115 | MP0001663_abnormal_digestive_system | 0.91841410 |
116 | MP0003950_abnormal_plasma_membrane | 0.90427201 |
117 | MP0003866_abnormal_defecation | 0.90260721 |
118 | MP0002452_abnormal_antigen_presenting | 0.89680105 |
119 | MP0000249_abnormal_blood_vessel | 0.89090376 |
120 | MP0006082_CNS_inflammation | 0.88114637 |
121 | MP0003868_abnormal_feces_composition | 0.88086761 |
122 | MP0000490_abnormal_crypts_of | 0.87974824 |
123 | MP0005075_abnormal_melanosome_morpholog | 0.85552399 |
124 | MP0001845_abnormal_inflammatory_respons | 0.85550504 |
125 | MP0005395_other_phenotype | 0.85385353 |
126 | MP0003045_fibrosis | 0.83935561 |
127 | MP0000681_abnormal_thyroid_gland | 0.83033000 |
128 | MP0001293_anophthalmia | 0.82936727 |
129 | MP0000537_abnormal_urethra_morphology | 0.82705402 |
130 | MP0009384_cardiac_valve_regurgitation | 0.82003184 |
131 | MP0001191_abnormal_skin_condition | 0.81875481 |
132 | MP0000358_abnormal_cell_content/ | 0.81562615 |
133 | MP0000762_abnormal_tongue_morphology | 0.80993532 |
134 | MP0001697_abnormal_embryo_size | 0.80837610 |
135 | MP0008469_abnormal_protein_level | 0.80777536 |
136 | MP0003091_abnormal_cell_migration | 0.80477906 |
137 | MP0009643_abnormal_urine_homeostasis | 0.80209961 |
138 | MP0005365_abnormal_bile_salt | 0.80177665 |
139 | MP0002006_tumorigenesis | 0.77523536 |
140 | MP0005503_abnormal_tendon_morphology | 0.77476369 |
141 | MP0002090_abnormal_vision | 0.76230282 |
142 | MP0000383_abnormal_hair_follicle | 0.75690865 |
143 | MP0005167_abnormal_blood-brain_barrier | 0.74445560 |
144 | MP0003315_abnormal_perineum_morphology | 0.74002118 |
145 | MP0004147_increased_porphyrin_level | 0.72950896 |
146 | MP0005332_abnormal_amino_acid | 0.71703955 |
147 | MP0003828_pulmonary_edema | 0.71654531 |
148 | MP0002102_abnormal_ear_morphology | 0.70768474 |
149 | MP0002405_respiratory_system_inflammati | 0.70266346 |
150 | MP0001727_abnormal_embryo_implantation | 0.70222389 |
151 | MP0002723_abnormal_immune_serum | 0.70024802 |
152 | MP0002084_abnormal_developmental_patter | 0.69631063 |
153 | MP0002136_abnormal_kidney_physiology | 0.69430532 |
154 | MP0003448_altered_tumor_morphology | 0.69318926 |
155 | MP0002139_abnormal_hepatobiliary_system | 0.69127551 |
156 | MP0000313_abnormal_cell_death | 0.69051500 |
157 | MP0005319_abnormal_enzyme/_coenzyme | 0.68946446 |
158 | MP0005636_abnormal_mineral_homeostasis | 0.68192562 |
159 | MP0000467_abnormal_esophagus_morphology | 0.68120395 |
160 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68038834 |
161 | MP0001672_abnormal_embryogenesis/_devel | 0.66429838 |
162 | MP0005380_embryogenesis_phenotype | 0.66429838 |
163 | MP0002080_prenatal_lethality | 0.63190000 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Lipid accumulation in hepatocytes (HP:0006561) | 4.01536898 |
2 | Increased hepatocellular lipid droplets (HP:0006565) | 3.92302239 |
3 | Right ventricular cardiomyopathy (HP:0011663) | 3.88141983 |
4 | Acute necrotizing encephalopathy (HP:0006965) | 3.56719225 |
5 | Abnormality of the nasal mucosa (HP:0000433) | 3.44931183 |
6 | Abnormality of the anterior horn cell (HP:0006802) | 3.42724276 |
7 | Degeneration of anterior horn cells (HP:0002398) | 3.42724276 |
8 | Vacuolated lymphocytes (HP:0001922) | 3.36662232 |
9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.30660705 |
10 | Protrusio acetabuli (HP:0003179) | 3.22930812 |
11 | Interstitial pulmonary disease (HP:0006530) | 3.21406079 |
12 | Eczematoid dermatitis (HP:0000976) | 3.19195466 |
13 | Progressive macrocephaly (HP:0004481) | 3.18691235 |
14 | Acute encephalopathy (HP:0006846) | 2.98764403 |
15 | Nasal polyposis (HP:0100582) | 2.98502421 |
16 | Patchy hypopigmentation of hair (HP:0011365) | 2.94715295 |
17 | Atrophic scars (HP:0001075) | 2.91861621 |
18 | Mitochondrial inheritance (HP:0001427) | 2.90314424 |
19 | Abnormality of methionine metabolism (HP:0010901) | 2.89909265 |
20 | Renal Fanconi syndrome (HP:0001994) | 2.89312535 |
21 | Increased IgE level (HP:0003212) | 2.88863301 |
22 | Increased CSF lactate (HP:0002490) | 2.88003060 |
23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.86207207 |
24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.86207207 |
25 | Increased intramyocellular lipid droplets (HP:0012240) | 2.84712917 |
26 | Onycholysis (HP:0001806) | 2.84133763 |
27 | Increased cerebral lipofuscin (HP:0011813) | 2.82562014 |
28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.82325323 |
29 | Retinal dysplasia (HP:0007973) | 2.78038744 |
30 | Cerebral edema (HP:0002181) | 2.77045643 |
31 | Vertebral compression fractures (HP:0002953) | 2.76981766 |
32 | Posterior subcapsular cataract (HP:0007787) | 2.74340734 |
33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.72982589 |
34 | Sparse eyelashes (HP:0000653) | 2.69261360 |
35 | Abnormality of macrophages (HP:0004311) | 2.65837788 |
36 | Increased muscle lipid content (HP:0009058) | 2.62708346 |
37 | Fragile nails (HP:0001808) | 2.62398733 |
38 | Chronic otitis media (HP:0000389) | 2.62216523 |
39 | Neoplasm of head and neck (HP:0012288) | 2.59079634 |
40 | Esophageal neoplasm (HP:0100751) | 2.59079634 |
41 | Beaking of vertebral bodies (HP:0004568) | 2.58844247 |
42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.54196260 |
43 | Papillary thyroid carcinoma (HP:0002895) | 2.52737848 |
44 | Symptomatic seizures (HP:0011145) | 2.50881409 |
45 | Milia (HP:0001056) | 2.47206422 |
46 | Multiple enchondromatosis (HP:0005701) | 2.45381757 |
47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45170809 |
48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.45021391 |
49 | Type I transferrin isoform profile (HP:0003642) | 2.42648233 |
50 | Steatorrhea (HP:0002570) | 2.40893293 |
51 | Thin bony cortex (HP:0002753) | 2.40303253 |
52 | Aplastic anemia (HP:0001915) | 2.37594585 |
53 | Erythema (HP:0010783) | 2.37291438 |
54 | Vascular tortuosity (HP:0004948) | 2.37171608 |
55 | Thrombocytosis (HP:0001894) | 2.37067299 |
56 | Abnormality of renal resorption (HP:0011038) | 2.36225185 |
57 | Hypoglycemic coma (HP:0001325) | 2.34723594 |
58 | Exertional dyspnea (HP:0002875) | 2.34066317 |
59 | Abnormality of serum amino acid levels (HP:0003112) | 2.32517060 |
60 | Hepatocellular necrosis (HP:0001404) | 2.32401711 |
61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.32046676 |
62 | Aortic aneurysm (HP:0004942) | 2.31511331 |
63 | Abnormality of placental membranes (HP:0011409) | 2.31462807 |
64 | Amniotic constriction ring (HP:0009775) | 2.31462807 |
65 | Arterial tortuosity (HP:0005116) | 2.28381631 |
66 | Type II lissencephaly (HP:0007260) | 2.27829461 |
67 | Hepatic necrosis (HP:0002605) | 2.26820634 |
68 | Fragile skin (HP:0001030) | 2.26187907 |
69 | Abnormality of alanine metabolism (HP:0010916) | 2.24184062 |
70 | Hyperalaninemia (HP:0003348) | 2.24184062 |
71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.24184062 |
72 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.23979457 |
73 | Axonal loss (HP:0003447) | 2.21062476 |
74 | Aortic dissection (HP:0002647) | 2.20878028 |
75 | Oral leukoplakia (HP:0002745) | 2.20619924 |
76 | Woolly hair (HP:0002224) | 2.19388913 |
77 | Hypotrichosis (HP:0001006) | 2.19264519 |
78 | Chronic bronchitis (HP:0004469) | 2.19138132 |
79 | Intrahepatic cholestasis (HP:0001406) | 2.17716608 |
80 | Dysostosis multiplex (HP:0000943) | 2.17181834 |
81 | Nausea (HP:0002018) | 2.16073646 |
82 | Plantar hyperkeratosis (HP:0007556) | 2.16048462 |
83 | Congenital, generalized hypertrichosis (HP:0004540) | 2.14819488 |
84 | Abnormal hemoglobin (HP:0011902) | 2.14073558 |
85 | Respiratory failure (HP:0002878) | 2.13783505 |
86 | Lethargy (HP:0001254) | 2.12787448 |
87 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12688349 |
88 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12688349 |
89 | Abnormal protein glycosylation (HP:0012346) | 2.12688349 |
90 | Abnormal glycosylation (HP:0012345) | 2.12688349 |
91 | Micronodular cirrhosis (HP:0001413) | 2.12661845 |
92 | Premature rupture of membranes (HP:0001788) | 2.11718610 |
93 | Reduced antithrombin III activity (HP:0001976) | 2.11342011 |
94 | Peritonitis (HP:0002586) | 2.11111345 |
95 | Myositis (HP:0100614) | 2.10340971 |
96 | Megaloblastic anemia (HP:0001889) | 2.08722465 |
97 | Hyperactive renin-angiotensin system (HP:0000841) | 2.08287844 |
98 | * Diminished motivation (HP:0000745) | 2.07679759 |
99 | Sensory axonal neuropathy (HP:0003390) | 2.07537874 |
100 | Nonimmune hydrops fetalis (HP:0001790) | 2.07189744 |
101 | Fat malabsorption (HP:0002630) | 2.05687695 |
102 | Methylmalonic acidemia (HP:0002912) | 2.05593288 |
103 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.05171473 |
104 | Median cleft lip (HP:0000161) | 2.05146388 |
105 | Increased serum lactate (HP:0002151) | 2.05012204 |
106 | Respiratory difficulties (HP:0002880) | 2.04823812 |
107 | Hypoglycemic seizures (HP:0002173) | 2.04774765 |
108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.04468967 |
109 | Lactic acidosis (HP:0003128) | 2.03958645 |
110 | White forelock (HP:0002211) | 2.03870656 |
111 | Abnormality of vitamin B metabolism (HP:0004340) | 2.03803317 |
112 | Hydroxyprolinuria (HP:0003080) | 2.03549102 |
113 | Abnormality of proline metabolism (HP:0010907) | 2.03549102 |
114 | Exercise intolerance (HP:0003546) | 2.02655514 |
115 | Rhabdomyosarcoma (HP:0002859) | 2.02627598 |
116 | Thyroid carcinoma (HP:0002890) | 2.02389023 |
117 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.01503913 |
118 | Chronic diarrhea (HP:0002028) | 2.01473894 |
119 | Conjugated hyperbilirubinemia (HP:0002908) | 1.99365761 |
120 | Abnormality of urine glucose concentration (HP:0011016) | 1.96417870 |
121 | Glycosuria (HP:0003076) | 1.96417870 |
122 | Increased serum ferritin (HP:0003281) | 1.95556388 |
123 | Petechiae (HP:0000967) | 1.94743450 |
124 | Abnormal albumin level (HP:0012116) | 1.93452829 |
125 | Hypoalbuminemia (HP:0003073) | 1.93452829 |
126 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.92847519 |
127 | Biliary tract neoplasm (HP:0100574) | 1.92812600 |
128 | Breast carcinoma (HP:0003002) | 1.92436426 |
129 | Autoamputation (HP:0001218) | 1.91876303 |
130 | Hyperparathyroidism (HP:0000843) | 1.90960165 |
131 | Orchitis (HP:0100796) | 1.90275474 |
132 | Cervical subluxation (HP:0003308) | 1.88356372 |
133 | Mucopolysacchariduria (HP:0008155) | 1.87319956 |
134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87319956 |
135 | Hyperphosphaturia (HP:0003109) | 1.85922416 |
136 | Neurofibrillary tangles (HP:0002185) | 1.82780927 |
137 | Hypergammaglobulinemia (HP:0010702) | 1.82349106 |
138 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.82190487 |
139 | Long clavicles (HP:0000890) | 1.81764728 |
140 | Tetraparesis (HP:0002273) | 1.81363920 |
141 | Leukodystrophy (HP:0002415) | 1.81330778 |
142 | Asymmetric septal hypertrophy (HP:0001670) | 1.80729008 |
143 | Abnormal biliary tract morphology (HP:0012440) | 1.80561877 |
144 | Stenosis of the external auditory canal (HP:0000402) | 1.80265477 |
145 | Increased serum pyruvate (HP:0003542) | 1.79749279 |
146 | Hematochezia (HP:0002573) | 1.78390644 |
147 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.77372524 |
148 | Cerebral hemorrhage (HP:0001342) | 1.77089708 |
149 | Multiple lipomas (HP:0001012) | 1.76734528 |
150 | Malnutrition (HP:0004395) | 1.75417289 |
151 | Volvulus (HP:0002580) | 1.74713964 |
152 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.74305348 |
153 | Microcytic anemia (HP:0001935) | 1.74283661 |
154 | Palpitations (HP:0001962) | 1.73653826 |
155 | Lower limb hyperreflexia (HP:0002395) | 1.72827951 |
156 | Macrocytic anemia (HP:0001972) | 1.72706096 |
157 | Polygenic inheritance (HP:0010982) | 1.72569871 |
158 | Neoplasm of the small intestine (HP:0100833) | 1.71579805 |
159 | Uterine neoplasm (HP:0010784) | 1.70821417 |
160 | Stridor (HP:0010307) | 1.70523036 |
161 | Hypothermia (HP:0002045) | 1.69965543 |
162 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.69908507 |
163 | Chronic sinusitis (HP:0011109) | 1.68696189 |
164 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.68144257 |
165 | Dilatation of the ascending aorta (HP:0005111) | 1.67793901 |
166 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.67467106 |
167 | Bronchitis (HP:0012387) | 1.66368491 |
168 | Abnormal number of erythroid precursors (HP:0012131) | 1.65787711 |
169 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.64407603 |
170 | Conjunctival hamartoma (HP:0100780) | 1.64284814 |
171 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.64277457 |
172 | Ectopia lentis (HP:0001083) | 1.63020459 |
173 | Osteolytic defects of the hand bones (HP:0009699) | 1.60391127 |
174 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.60391127 |
175 | Abnormal platelet function (HP:0011869) | 1.59963639 |
176 | Impaired platelet aggregation (HP:0003540) | 1.59963639 |
177 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.59658709 |
178 | Abnormality of the pericardium (HP:0001697) | 1.57709069 |
179 | Distal arthrogryposis (HP:0005684) | 1.56805216 |
180 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.56482054 |
181 | Proximal tubulopathy (HP:0000114) | 1.55054559 |
182 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.54171686 |
183 | Generalized amyotrophy (HP:0003700) | 1.53633663 |
184 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.53516528 |
185 | Episodic fever (HP:0001954) | 1.53182331 |
186 | Pili torti (HP:0003777) | 1.52541490 |
187 | Facial diplegia (HP:0001349) | 1.52480429 |
188 | Hypochromic anemia (HP:0001931) | 1.50912571 |
189 | Autoimmune hemolytic anemia (HP:0001890) | 1.50388791 |
190 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.50118893 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EIF2AK3 | 3.64131767 |
2 | PIM2 | 3.30762228 |
3 | TESK1 | 3.14580237 |
4 | EIF2AK1 | 2.83010971 |
5 | NEK1 | 2.80158062 |
6 | TRIM28 | 2.78852544 |
7 | BUB1 | 2.48820076 |
8 | SRPK1 | 2.34989330 |
9 | ACVR1B | 2.34913184 |
10 | MAPKAPK3 | 2.33549649 |
11 | EPHA3 | 2.33262311 |
12 | MAP3K12 | 2.22870714 |
13 | TGFBR2 | 2.18130174 |
14 | BCR | 2.12586061 |
15 | RIPK4 | 2.03222584 |
16 | KDR | 2.02662780 |
17 | SCYL2 | 1.97316976 |
18 | TIE1 | 1.97194165 |
19 | ARAF | 1.96203217 |
20 | MST4 | 1.92116548 |
21 | FER | 1.89799347 |
22 | STK38L | 1.89729080 |
23 | MAPKAPK5 | 1.86530658 |
24 | LIMK1 | 1.84926358 |
25 | FRK | 1.84417885 |
26 | ERN1 | 1.80935449 |
27 | MUSK | 1.79492568 |
28 | TTK | 1.78417786 |
29 | NME2 | 1.77580198 |
30 | ERBB3 | 1.77365634 |
31 | STK39 | 1.75301450 |
32 | WEE1 | 1.74682397 |
33 | TBK1 | 1.71929908 |
34 | TGFBR1 | 1.67301545 |
35 | TSSK6 | 1.67131151 |
36 | LRRK2 | 1.64920947 |
37 | BRSK2 | 1.63048175 |
38 | BMPR2 | 1.58270268 |
39 | EPHB1 | 1.58151339 |
40 | PRKG2 | 1.54452694 |
41 | MAP3K11 | 1.52437996 |
42 | MKNK2 | 1.52323483 |
43 | KIT | 1.50305014 |
44 | PLK3 | 1.48795895 |
45 | STK16 | 1.45397406 |
46 | EPHA2 | 1.43395744 |
47 | MATK | 1.41305208 |
48 | KSR2 | 1.40527433 |
49 | PDK3 | 1.37254753 |
50 | PDK4 | 1.37254753 |
51 | CAMKK2 | 1.34854569 |
52 | MKNK1 | 1.31356898 |
53 | TRIB3 | 1.28147262 |
54 | MST1R | 1.27767740 |
55 | STK3 | 1.26872901 |
56 | MAP3K2 | 1.24290879 |
57 | FLT3 | 1.21821136 |
58 | MAP3K3 | 1.17217476 |
59 | FGFR4 | 1.14766961 |
60 | EIF2AK2 | 1.13872405 |
61 | MAP3K13 | 1.12945330 |
62 | PDK2 | 1.12841352 |
63 | STK24 | 1.11787098 |
64 | CDC7 | 1.11084322 |
65 | TYK2 | 1.11032865 |
66 | NUAK1 | 1.10865181 |
67 | MAP2K6 | 1.10384251 |
68 | CSNK1G1 | 1.08953371 |
69 | ERBB4 | 1.07952316 |
70 | OXSR1 | 1.07395719 |
71 | LATS1 | 1.06080265 |
72 | PLK1 | 1.06066314 |
73 | LMTK2 | 1.05471992 |
74 | MAP3K1 | 1.05064231 |
75 | DYRK1B | 1.03039187 |
76 | EEF2K | 1.02977961 |
77 | PLK4 | 1.02384465 |
78 | BMPR1B | 1.02344624 |
79 | SIK3 | 1.01695159 |
80 | BCKDK | 1.00692024 |
81 | RPS6KA4 | 1.00449609 |
82 | ILK | 0.98435326 |
83 | CSNK1G3 | 0.95242017 |
84 | PASK | 0.94931225 |
85 | PBK | 0.94922890 |
86 | MYLK | 0.94781311 |
87 | DDR2 | 0.90006665 |
88 | PKN2 | 0.86689395 |
89 | PTK6 | 0.85781113 |
90 | RIPK1 | 0.85346126 |
91 | JAK1 | 0.85046269 |
92 | CSNK1G2 | 0.84086046 |
93 | TRPM7 | 0.84007841 |
94 | DYRK3 | 0.83739994 |
95 | ZAP70 | 0.83635859 |
96 | BLK | 0.83099807 |
97 | NTRK1 | 0.82334360 |
98 | MAP2K1 | 0.82158010 |
99 | RAF1 | 0.78487630 |
100 | LATS2 | 0.78468996 |
101 | ABL2 | 0.77241276 |
102 | CSNK1A1L | 0.75228721 |
103 | PLK2 | 0.71865481 |
104 | PDGFRA | 0.71687259 |
105 | RPS6KB2 | 0.70782256 |
106 | CDK6 | 0.69467231 |
107 | PTK2B | 0.68816649 |
108 | MINK1 | 0.68403523 |
109 | PAK3 | 0.68149372 |
110 | NLK | 0.66556082 |
111 | MOS | 0.65940622 |
112 | RET | 0.63658742 |
113 | TNIK | 0.63272824 |
114 | MAP3K14 | 0.62790401 |
115 | MAP3K9 | 0.61522747 |
116 | STK10 | 0.61039202 |
117 | HIPK2 | 0.60817468 |
118 | MAP2K3 | 0.59856637 |
119 | JAK3 | 0.59184988 |
120 | GRK7 | 0.57827703 |
121 | IRAK1 | 0.57728914 |
122 | CDK19 | 0.57355366 |
123 | NME1 | 0.56672734 |
124 | PAK4 | 0.55816599 |
125 | CSF1R | 0.55423771 |
126 | MET | 0.55219961 |
127 | NEK6 | 0.55175339 |
128 | VRK2 | 0.53455371 |
129 | PTK2 | 0.50796561 |
130 | IKBKE | 0.49596275 |
131 | ALK | 0.48659355 |
132 | YES1 | 0.47835570 |
133 | SYK | 0.47687619 |
134 | MAP2K2 | 0.47584010 |
135 | AURKB | 0.47559001 |
136 | CAMK2D | 0.46740291 |
137 | PIK3CA | 0.46449965 |
138 | CAMKK1 | 0.45082068 |
139 | IRAK3 | 0.44788588 |
140 | CSNK2A1 | 0.44414873 |
141 | MAP3K5 | 0.43564672 |
142 | MAPKAPK2 | 0.42198758 |
143 | PIK3CG | 0.40744286 |
144 | BRSK1 | 0.40583395 |
145 | FGFR3 | 0.40577130 |
146 | FGFR1 | 0.40422234 |
147 | KSR1 | 0.39819536 |
148 | PRKCE | 0.39005904 |
149 | CSNK2A2 | 0.38654332 |
150 | VRK1 | 0.34166152 |
151 | MAPK15 | 0.34136387 |
152 | IKBKB | 0.33689694 |
153 | TEC | 0.31752982 |
154 | BTK | 0.31630419 |
155 | TTN | 0.31208734 |
156 | EGFR | 0.30172952 |
157 | FGR | 0.30038394 |
158 | GRK1 | 0.29495977 |
159 | MAP3K8 | 0.27782403 |
160 | CSNK1E | 0.24514045 |
161 | DMPK | 0.24189357 |
162 | ATM | 0.23270378 |
163 | CAMK2G | 0.23069230 |
164 | DAPK1 | 0.22572305 |
165 | NEK2 | 0.22263346 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.74508100 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.61501118 |
3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.49444548 |
4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.45757110 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 2.25227585 |
6 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.20844485 |
7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.19200921 |
8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.13042983 |
9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.94799658 |
10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.89958427 |
11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89235680 |
12 | RNA transport_Homo sapiens_hsa03013 | 1.85729419 |
13 | Shigellosis_Homo sapiens_hsa05131 | 1.76948930 |
14 | Salmonella infection_Homo sapiens_hsa05132 | 1.75863475 |
15 | Spliceosome_Homo sapiens_hsa03040 | 1.67883704 |
16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.67724836 |
17 | DNA replication_Homo sapiens_hsa03030 | 1.60369114 |
18 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.57635715 |
19 | Legionellosis_Homo sapiens_hsa05134 | 1.56160249 |
20 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53219247 |
21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51721806 |
22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.51441111 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.50902512 |
24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50589252 |
25 | Pertussis_Homo sapiens_hsa05133 | 1.50540152 |
26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46085799 |
27 | RNA polymerase_Homo sapiens_hsa03020 | 1.45620493 |
28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45530479 |
29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.44732056 |
30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43403120 |
31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39371248 |
32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38200951 |
33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35039668 |
34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33358767 |
35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32370726 |
36 | Malaria_Homo sapiens_hsa05144 | 1.31362487 |
37 | Lysosome_Homo sapiens_hsa04142 | 1.31324832 |
38 | Homologous recombination_Homo sapiens_hsa03440 | 1.28175141 |
39 | Phagosome_Homo sapiens_hsa04145 | 1.27260878 |
40 | Platelet activation_Homo sapiens_hsa04611 | 1.25900158 |
41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25848691 |
42 | Cell cycle_Homo sapiens_hsa04110 | 1.24240440 |
43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23891701 |
44 | Protein export_Homo sapiens_hsa03060 | 1.23734902 |
45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22082587 |
46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19552496 |
47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.19124608 |
48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17911159 |
49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17740182 |
50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17359392 |
51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16469652 |
52 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16214213 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 1.13652237 |
54 | Mineral absorption_Homo sapiens_hsa04978 | 1.13139153 |
55 | RNA degradation_Homo sapiens_hsa03018 | 1.12277241 |
56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12111054 |
57 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12024921 |
58 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11771368 |
59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11707524 |
60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08978087 |
61 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06689908 |
62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.04689145 |
63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04555160 |
64 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03862198 |
65 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03691385 |
66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02879560 |
67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02749138 |
68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01671752 |
69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01157163 |
70 | Bladder cancer_Homo sapiens_hsa05219 | 1.00992983 |
71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00520223 |
72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99603135 |
73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98496870 |
74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98455076 |
75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98335101 |
76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97087109 |
77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96820684 |
78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94764807 |
79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94753826 |
80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93795642 |
81 | Focal adhesion_Homo sapiens_hsa04510 | 0.93169545 |
82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93075341 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92996940 |
84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92137462 |
85 | Base excision repair_Homo sapiens_hsa03410 | 0.91615775 |
86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90892916 |
87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90073044 |
88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88743233 |
89 | Tuberculosis_Homo sapiens_hsa05152 | 0.88737404 |
90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87977035 |
91 | Hepatitis C_Homo sapiens_hsa05160 | 0.85777444 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85395854 |
93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85122550 |
94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84941871 |
95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82385843 |
96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82321927 |
97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81987487 |
98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.81400488 |
99 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81137213 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80132896 |
101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78608292 |
102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78252360 |
103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78058316 |
104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76232285 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74757168 |
106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73788551 |
107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73613403 |
108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73359286 |
109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72421171 |
110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68772340 |
111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67134748 |
112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66827852 |
113 | * Endocytosis_Homo sapiens_hsa04144 | 0.66268741 |
114 | Purine metabolism_Homo sapiens_hsa00230 | 0.65948953 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65547640 |
116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64635308 |
117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64550084 |
118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62607375 |
119 | Peroxisome_Homo sapiens_hsa04146 | 0.62006054 |
120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61210277 |
121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60674656 |
122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60100105 |
123 | Proteasome_Homo sapiens_hsa03050 | 0.60099102 |
124 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59381940 |
125 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59039854 |
126 | Tight junction_Homo sapiens_hsa04530 | 0.58210963 |
127 | Influenza A_Homo sapiens_hsa05164 | 0.57720654 |
128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57610887 |
129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55679870 |
130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55410061 |
131 | Ribosome_Homo sapiens_hsa03010 | 0.53739697 |
132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52699212 |
133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52640315 |
134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52328800 |
135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51706806 |
136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50741342 |
137 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50347813 |
138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50256902 |
139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49093399 |
140 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48887472 |
141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48444972 |
142 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48418125 |
143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48168071 |
144 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47601408 |
145 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46607509 |
146 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46597154 |
147 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45934426 |
148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44067903 |
149 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43862899 |
150 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43356571 |
151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42842270 |
152 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42525832 |
153 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41812634 |
154 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40871149 |
155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40419184 |
156 | Adherens junction_Homo sapiens_hsa04520 | 0.39939498 |
157 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38476205 |
158 | Asthma_Homo sapiens_hsa05310 | 0.36759015 |